EUVIMEDEUVIMED entdecken
Crossref

Synthesis of a Selective Orexin 1 Receptor Antagonist: Development of a Manufacturing Process–Part 1

John S. Carey, Jonathan C. Churchill, James D. Firth, Paul Leong, Sophie L. Smith

Organic Process Research & Development · 18.11.2026

DOI: 10.1021/acs.oprd.6c00296 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Organic Process Research & Development, online erschienen am 18.11.2026. Verfasst von John S. Carey und 4 weiteren Autor:innen. Die Arbeit nennt 13 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In campaign 1, 103.9 kg of (S)-2-(N-benzyl-N-methylamino)-1-propanamine d-tartaric acid salt (4) was prepared in 3 stages from l-alaninamide·HCl. The Stage 2 reaction, the reductive amination of (S)-2-benzylaminopropionamide (2) with aqueous formalin using H2, Pd/C, and THF as solvent, proved to be nonrobust. Ahead of campaign 2, the Stage 2 and 3 processes were redeveloped to provide a higher yielding and more robust set of reaction conditions. The key change was to conduct the reductive amination of (S)-2-benzylaminopropionamide (2) with aqueous formalin using NaBH4 in MeOH as solvent while maintaining a constant pH (pH = 8.5) by the addition of acetic acid. In campaign 2, (S)-2-(N-benzyl-N-methylamino)-1-propanamine was isolated as the d-mandelic acid salt. A total of 373 kg of (S)-2-(N-benzyl-N-methylamino)-1-propanamine d-mandelic acid salt was produced in high yield and excellent quality. (S)-2-(N-Benzyl-N-methylamino)-1-propanamine is a key intermediate in the synthesis of the orexin 1 receptor antagonist C4X3256.

Zitieren

APA

Carey, J. S., Churchill, J. C., Firth, J. D., Leong, P., & Smith, S. L. (2026). Synthesis of a Selective Orexin 1 Receptor Antagonist: Development of a Manufacturing Process–Part 1. Organic Process Research & Development. https://doi.org/10.1021/acs.oprd.6c00296

Vancouver

Carey JS, Churchill JC, Firth JD, Leong P, Smith SL. Synthesis of a Selective Orexin 1 Receptor Antagonist: Development of a Manufacturing Process–Part 1. Organic Process Research & Development. 2026. doi:10.1021/acs.oprd.6c00296

BibTeX
@article{Carey2026,
  author = {Carey, John S. and Churchill, Jonathan C. and Firth, James D. and Leong, Paul and Smith, Sophie L.},
  title = {Synthesis of a Selective Orexin 1 Receptor Antagonist: Development of a Manufacturing Process–Part 1},
  journal = {Organic Process Research & Development},
  year = {2026},
  doi = {10.1021/acs.oprd.6c00296}
}
Kostenlos starten →